November
Medicinal Chemistry
Strategy Meeting East Coast USA 2023
Reinvigorating Productivity in Pharma Biotech Through Advanced Technologies and Innovative Techniques that Interrogate Activity and Mechanisms
What makes our strategy meetings unique?

Roundtable Discussions
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking
With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.

Personalised Agenda
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems
We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Meet Our 2023 Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Medicinal Chemistry strategy meeting.

Aaron Frank
Director and Head of Computational Chemistry Arrakis Therapeutics
Alex Nivorozhkin
Chief Scientific Officer Cybin
Allen Hopper
Senior Director of Drug Discovery Lucy Therapeutics
Blaise Lippa
SVP, Molecular Discovery Morphic Therapeutics
Byron DeLaBarre
Chief Technology Officer (CTO) & Head of Platform Pin Therapeutics
Diane Joseph-McCarthy
Executive Director, Bioengineering Technology & Entrepreneurship Center Boston University
Dominic Reynolds
Senior Vice President, Head of Drug Discovery Remix Therapeutics
Ed Olhava
Senior Vice President, Preclinical Development IFM Therapeutics
Horst Hemmerle
Executive Director Novartis
Ivan Efremov
VP, Head of Medicinal Chemistry Nereid Therapeutics
Jacques Dumas
Chief Scientific Officer Arrakis Therapeutics
Matthew Lucas
VP of Medical Chemistry Third Harmonic Bio
Prasoon Chaturvedi
Vice President, Head of DMPK C4 Therapeutics, Inc.
Richard Heidebrecht
Vice President and R&D Glycologix
Robert Goodnow
Head Drug Discovery Sciences Takeda
Sejal Patel
Vice President Chemistry Scorpion Therapeutics
Shankar Venkatraman
Executive Director, Chemistry IFM Therapeutics
Onur Atasoylu
Director, Head of Computational Chemistry IncyteWho Should Attend the Event?
Chief Executive Officers
Executive Vice Presidents
Vice Presidents
Executive Directors
Directors
Global Heads
Responsible For:
Medicinal Chemist
Computational Chemist
Translational
Chemist/Biology
In-Silico/In-vivo/In-vitro Chemist/Biologist
Chemical Biology
Molecular Chemist/Biologist
Hit and Lead Chemist
Small/Large Molecules Chemist
Drug Discovery or Drug Development
See Which Topics Are Discussed at the Strategy Meeting
Roundtable Tracks
1Evaluating the Effectiveness of Computer-Aided Drug Design, Artificial Intelligence and Machine Learning Tools In Fragment-Based Lead Discovery
-Diane Joseph-McCarthy
Executive Director, Bioengineering Technology & Entrepreneurship Center
Boston University
INNOVATIVE AND EMERGING MODALITIES
Building Successful Collaborations in Drug Discovery: Strategies for Effective Partnerships
-Richard Heidebrecht
Vice President and R&D
Glycologix
CHEMICAL BIOLOGY AND UNDRUGGABLES
Utilizing The New Warheads: Strategic Ways Of Developing Targeted Covalent Drugs (Topic TBC)
-Dominic Reynolds
Senior Vice President, Head of Drug Discovery
Remix Therapeutics
HIT IDENTIFICATION / LEAD OPTIMIZATION
Leveraging Predictive Model Techniques To Accelerate Hit-ToLead Optimization (Topic TBC)
-Onur Atasoylu
Director, Head of Computational Chemistry
Incyte
INTEGRATED DRUG DISCOVERY
Discovering New Drug Discovery Endpoints: Challenges And Opportunities
-Alex Nivorozhkin
Chief Scientific Officer
Cybin
DESIGN & SYNTHESIS
Emerging Trends in Medicinal Chemistry: Small Molecule Analog Synthesis and Structure-Activity Relationship (SAR) Strategies
-Richard Heidebrecht
Vice President and R&D
Glycologix
Roundtable Tracks
2Overcoming Challenges And Achieving Resilience: The Future of Biotech and Biopharma – AI-Guided In Drug Discovery and Development (Topic TBC)
INNOVATIVE AND EMERGING MODALITIES
Evaluation of Strategies for Drug Interaction Assessment To Guide Therapeutic Proteins For Biopharmaceutical Industry (Topic TBC)
CHEMICAL BIOLOGY AND UNDRUGGABLES
Potential Treatment For Rare Diseases: Innovative Techniques To Leverage Molecular Glues To Modify ProteinProtein Interactomes and Interactions (Topic TBC)
HIT IDENTIFICATION / LEAD OPTIMIZATION
Investigating Best Strategies To Accelerate The Progress of Compounds From Hit Identification Into Lead Optimization (Topic TBC)
INTEGRATED DRUG DISCOVERY
Overview of Fragment-Based Drug Discovery for Productivity and Improvement: Is There Panache Behind the Problems? (Topic TBC)
DESIGN & SYNTHESIS
Lipid Nanoparticles (LNPs) in Medicinal Chemistry: Synthesis, Formulation, and Delivery Optimization
Roundtable Tracks
3Approaches to Drug Design, Development, and Discovery: Looking at Challenges, Limitations, and Benefits for the Pharmaceutical and Biotechnology Industries
INNOVATIVE AND EMERGING MODALITIES
Big Drugs, Little Drugs – Exploring The Power of Large Molecule Improvements In Discovering Novel Drug Therapies
CHEMICAL BIOLOGY AND UNDRUGGABLES
Developing PROTAC Drugs: Fabricating Strategies for DMPK and ADMET To Overcome Challenges And Limitations
HIT IDENTIFICATION / LEAD OPTIMIZATION
Overlooked Components Of Drug Discovery/Optimization That Contributes To Clinical Drug Development Failure Rates: True Target Validation And Current Drug Optimization – Best Approach To Eradicate These Difficulties
INTEGRATED DRUG DISCOVERY
Enabling Scientific Development Towards Goals: Managing And Balancing The Internal And External Drug Development Capabilities
DESIGN & SYNTHESIS
Efficient Hit-to-Lead Design, Synthesis, and Screening Strategies for Drug Discovery
Roundtable Tracks
4Integrating AI/ML and Deep Learning Tools To Achieve Higher Accuracy For Predicting ADMET and DMPK Properties For Early Phase Drug Development
INNOVATIVE AND EMERGING MODALITIES
The Most Recent Advancements in Small Molecule Drug Design, Development, and Synthesis In Drug Bioavailability
CHEMICAL BIOLOGY AND UNDRUGGABLES
The Effective Designs and Optimization of PROTACs Benefits from Deep Learning and Molecular Simulations
HIT IDENTIFICATION / LEAD OPTIMIZATION
Understanding The Future Of High Throughput Screening And How We Might Be Able To Reach Undruggable Targets
INTEGRATED DRUG DISCOVERY
The Future Of Computer-Aided Drug Design (CADD) In Various Stages Of The Drug Development Pipelines, As Well As Pharma-Technological Advances
DESIGN & SYNTHESIS
Advancements in Chemical Route Exploration and Optimization for Enhanced API Synthesis in Medicinal Chemistry
Reasons To Attend the Strategy Meeting

Discussions on the advancements in targeted protein degradation andrnpushing past its boundaries.





Leveraging Artificial Intelligence and Machine Learning in accelerating therndevelopment of new drugs





Discuss approaches to further understand the interactions of undruggablerntargets and different Protein Degraders such as PROTACs, Molecular Glues,rnetc





Focusing on advancing interrogative techniques to improve the Drug Delivery System/Discovery: Modified mRNA, Nanoparticle-Mediated siRNA, Antibody-Drug Conjugates, and more
Press play to hear what your colleagues had to say…


Hotel & Venue
Le Méridien Boston Cambridge
Posh hotel minutes from Harvard Square and Beacon Hill, steps from shopping, dining & entertainment.
Hotel Details Map & Directions Parking









Want to find out more?
Find out more details about our Strategy Meetings and other news and events.
Here To Help
Want to know more? Interested in sponsoring the event? Need help registering your team?rnrnJust get in touch and a member of the team will be happy to help.